↗7 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$282KSold on the market
1Companies
Oct 15, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 202617:00 | Oct 15, 2026 | NRIXNurix Therapeutics, Inc. | Chief Scientific Officer | S · Sell10b5-1 | $25.00 | −1,452 | 117,227 | -1% | −$36K | ||
| Oct 15, 202617:00 | Oct 15, 2026 | NRIXNurix Therapeutics, Inc. | Chief Scientific Officer | M · Exercise10b5-1 | $1.86 | +1,452 | 118,679 | +1% | $3K | ||
| Sep 1, 202617:19 | Sep 1, 2026 | NRIXNurix Therapeutics, Inc. | Chief Scientific Officer | S · Sell10b5-1 | $25.47 | −1,452 | 117,227 | -1% | −$37K | ||
| Sep 1, 202617:19 | Sep 1, 2026 | NRIXNurix Therapeutics, Inc. | Chief Scientific Officer | M · Exercise10b5-1 | $1.86 | +1,452 | 118,679 | +1% | $3K | ||
| Aug 5, 202618:59 | Aug 5, 2026 | NRIXNurix Therapeutics, Inc. | Chief Scientific Officer | S · Sell10b5-1 | $25.00 | −4,356 | 117,227 | -4% | −$109K | ||
| Aug 5, 202618:59 | Aug 5, 2026 | NRIXNurix Therapeutics, Inc. | Chief Scientific Officer | M · Exercise10b5-1 | $1.86 | +4,356 | 121,583 | +4% | $8K | ||
| Aug 5, 202606:39 | Aug 4, 2026 | NRIXNurix Therapeutics, Inc. | Chief Scientific Officer | S · Sell10b5-1 | $24.36 | −4,111 | 117,227 | -3% | −$100K |